Darren S Cline insider trades

Open-market stock purchases and sales by Darren S Cline, Director at Pliant Therapeutics, Inc, from SEC Form 4 filings since Mar 13, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -82%.

Recent trades

DateStockTradeValue
Jun 11, 2026PLRX Pliant Therapeutics, IncBought (not open market)—
Mar 24, 2026PYXS Pyxis Oncology, IncBought (not open market)—
Jan 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Jan 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—

Companies traded

  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
  • PYXS Pyxis Oncology, Inc: 1 buy, last Mar 24, 2026
  • XENE Xenon Pharmaceuticals Inc: other filings, last Jan 9, 2026
  • IMPL Impel Pharmaceuticals Inc: other filings, last Jun 16, 2023
  • GWPH GW Pharmaceuticals plc: other filings, last May 5, 2021
  • STML Stemline Therapeutics Inc: other filings, last Jun 10, 2020
  • SGEN Seattle Genetics Inc /WA: 26 sales, last Nov 29, 2018

Get free alerts when Darren S Cline files a new trade →